Business Context and Reporting Period
Company: Herbalife Ltd.
Filing Type: Form 8-K (Current Report)
Date of Report: November 1, 2016
Reporting Period: Fiscal quarter ended September 30, 2016 (financial results announced via press release attached as Exhibit 99.1).
Key Financial Metrics
This Form 8-K serves as a notification of the release of financial results for the quarter ended September 30, 2016. The filing text itself does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the attached press release (Exhibit 99.1) and are not detailed in the body of this report.
Material Changes and Executive Leadership
The primary material change disclosed in this filing is a significant leadership transition effective June 1, 2017 (the "Transition Date"):
- Richard P. Goudis: Appointed as Chief Executive Officer (CEO). Previously served as Chief Operating Officer since 2010 and Chief Financial Officer since 2004.
- Michael O. Johnson: Appointed as Executive Chairman. Previously served as CEO since 2003 and Chairman of the Board since 2007.
Compensation Arrangements and Severance
New employment agreements and severance plans were established in connection with the leadership transition:
- Mr. Goudis (CEO):
- Annual Salary: $1,000,000.
- Target Annual Bonus: 120% of annual salary.
- Equity: Entitled to performance share units with a grant date fair value of $5,000,000 (reduced by 2017 ordinary course grants).
- Severance: Eligible for a lump sum payment of 2.0x annualized base salary upon termination without Cause or for Good Reason (reduced to 1.5x after five years of participation), plus pro-rata bonus.
- Mr. Johnson (Executive Chairman):
- Annual Salary: $650,000.
- Target Annual Bonus: 80% of annual salary.
- Severance: Previous severance entitlements under his 2008 agreement terminate; no new severance terms detailed in this text beyond the termination of the old agreement.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q3 2016 revenue, earnings, and cash flow figures, as they are not listed in the 8-K text.
- Verify the exact terms of the "Severance Plan" regarding the definition of "Cause" and "Good Reason" to understand payout triggers.
- Confirm the final grant date fair value of Mr. Goudis's $5,000,000 performance share units after the reduction for 2017 ordinary course grants.
- Monitor the transition timeline to ensure the effective date of June 1, 2017, is met without delay.